A Phase III trial of MicroStat
Phase of Trial: Phase III
Latest Information Update: 13 Nov 2018
At a glance
- Drugs Phenylephrine/tropicamide (Primary)
- Indications Mydriasis
- Focus Therapeutic Use
- 13 Nov 2018 Accoding to an Eyenovia media release,U.S. Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) application, and this trial is expected to begin in late November.
- 31 Aug 2018 New trial record
- 14 Aug 2018 Accoding to an Eyenovia media release, the company is planning to initiate the trial in H2 2018 and report results in H1 2019.